Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Finasteride may help reduce opioid use.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Fadrozole and finasteride change gene expression related to sex hormones and thyroid hormones in frog larvae development.

Finasteride reduces AML cell growth by inhibiting androgen receptors.

Stopping nalfurafine reversed hair loss in a hemodialysis patient.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Frontal fibrosing alopecia is increasing, especially in postmenopausal women, and treatment with finasteride can improve it.

Tamsulosin increases the risk of floppy iris during eye surgery.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Dutasteride may help treat frontal fibrosing alopecia.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

JAK inhibitors might help treat Lichen Planopilaris, but more research is needed.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

New compounds may help treat heart disease by activating specific potassium channels.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.